An experienced legal, regulatory and compliance leader and harm reduction thought leader, Patricia Kovacevic’s career comprises leading senior legal and regulatory positions with U.S. Food and Drug Administration-regulated multinationals, including Philip Morris International and Lorillard, as well as partner roles with premier global law firms. At present, she is general counsel and head of external affairs for Cryomass Technologies Inc., a U.S. listed company providing adjacent services to the cannabis industry, which has recently acquired patented technology (the CryomMass Refinement System) to fully separate trichomes from biomass. Her expertise includes senior management roles and leading multinational, cross-disciplinary teams, with a focus on corporate law, FDA and EU regulatory, compliance, M&A, U.S. and global food, drug, nicotine and consumer goods regulation, cannabis/CBD regulation, external affairs and the legal framework applicable to marketing, media communications, investigations, FCPA, trade sanctions, privacy, intellectual property, product development and launch. She also led cross-disciplinary teams engaged in scientific research efforts. Kovacevic served on various trade association bodies and conference advisory boards. She authored several articles on nicotine regulation, co-authored an academic treatise, “The Regulation of E-Cigarettes,” as well as various other papers, and is often invited as a keynote speaker or panelist for global conferences and government agencies’ public hearings. Kovacevic is an attorney admitted to practice in New York, before the U.S. Tax Court, before the U.S. Court of International Trade and before the Supreme Court of the United States. She holds a Juris Doctor (doctor of law) degree from Columbia Law School in New York, and she completed the Harvard Business School Corporate Leader executive education program. Kovacevic speaks several languages fluently, including French, Italian, Spanish, Romanian and Croatian.